Abstract:Background Angiogenesis plays an important role in tumor growth and metastasis, therefore antiangiogenic therapy was widely investigated as a promising approach for cancer therapy. Recently, pigment epithelium-derived factor (PEDF) has been shown to be the most potent inhibitor of angiogenesis. Adeno-associated virus (AAV) vectors have been intensively studied due to their wide tropisms, nonpathogenicity, and long-term transgene expression in vivo . The objective of this work was to evaluate the ability of AAV-mediated human PEDF (hPEDF) as a potent tumor suppressor and a potential candidate for cancer gene therapy. Methods Recombinant AAV 2 encoding hPEDF (rAAV 2 -hPEDF) was constructed and produced, and then was assigned for in vitro and in vivo experiments. Conditioned medium from cells infected with rAAV 2 -hPEDF was used for cell proliferation and tube formation tests of human umbilical vein endothelial cells (HUVECs). Subsequently, colorectal peritoneal carcinomatosis (CRPC) mouse model was established and treated with rAAV 2 -hPEDF. Therapeutic efficacy of rAAV 2 -hPEDF were investigated, including tumor growth and metastasis, survival time, microvessel density (MVD) and apoptosis index of tumor tissues, and hPEDF levels in serum and ascites. Results rAAV 2 -hPEDF was successfully constructed, and transmission electron microscope (TEM) showed that rAAV 2 -hPEDF particles were non-enveloped icosahedral shape with a diameter of approximately 20 nm. rAAV 2 -hPEDF-infected cells expressed hPEDF protein, and the conditioned medium from infected cells inhibited proliferation and tube-formation of HUVECs in vitro . Furthermore, in CRPC mouse model, rAAV 2 -hPEDF significantly suppressed tumor growth and metastasis, and prolonged survival time of treated mice. Immunofluorescence studies indicated that rAAV 2 -hPEDF could inhibit angiogenesis and induce apoptosis in tumor tissues. Besides, hPEDF levels in serum and ascites of rAAV 2 -hPEDF-treated mice were significant higher than those in rAAV 2 -null or normal saline (NS) groups. Conclusions Thus, our results suggest that rAAV 2 -hPEDF may be a potential candidate as an antiangiogenic therapy agent.

Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma

Systemically Administered Liposome-Encapsulated Ad-PEDF Potentiates the Anti-Cancer Effects in Mouse Lung Metastasis Melanoma

AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model

Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model.

Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation.

Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration

Prevention and treatment of B16 melanoma by adeno-associated virus-mediated human angiostatin(K1-5) gene transfection

[Anti-Tumor Effect Through Human Endostatin Gene Transfer in Mice Bearing B16 Melanoma].

[The Influence of Ad-AVEGF165 on Human Malignant Melanoma Growth in Nude Mice].

AAV-mediated Gene Transfer of Human Pigment Epithelium-Derived Factor Inhibits Lewis Lung Carcinoma Growth in Mice.

The Pigment Epithelial-Derived Factor Gene Loaded in PLGA Nanoparticles for Therapy of Colon Carcinoma.

Pigment epithelium-derived factor inhibits T24 bladder cancer cell growth in vitro and in vivo

Inhibition of Tumor Growth by Recombinant Adenovirus Containing Human Lactoferrin Through Inducing Tumor Cell Apoptosis in Mice Bearing Emt6 Breast Cancer

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Anti-Tumor Effects of Engineered VNP20009-Abvec-Igκ-mPD-1 Strain in Melanoma Mice Via Combining the Oncolytic Therapy and Immunotherapy

Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma

Synergistic Antitumor Effect of Recombinant Adeno-Associated Virus-Mediated Pigment Epithelium-Derived Factor with Hyperthermia on Solid Tumor.

[Effects of Pigment Epithelial Derived Factor Gene on Growth of Lung Cancer Cell and Neovascularization: Experiments with Lung Cancer Cells and Chick Embryos].

Phosphomimetic Mutants of Pigment Epithelium-Derived Factor with Enhanced Anti-Choroidal Melanoma Cell Activity in Vitro and in Vivo.

Growth Suppression of Cervical Carcinoma by Pigment Epithelium-Derived Factor Via Anti-Angiogenesis.

Adenovirus-mediated Human Endostatin Gene Delivery in the Treatment of Mouse Melanoma